Phase II, open-label trial of lapatinib and vinorelbine in women with previously treated HER2-positive metastatic breast cancer

MLA

Chan, Arlene, et al. Phase II, Open-Label Trial of Lapatinib and Vinorelbine in Women with Previously Treated HER2-Positive Metastatic Breast Cancer. 2014. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1033960980&authtype=sso&custid=ns315887.

APA

Chan, A., Shannon, C., De Boer, R., Baron-Hay, S., Redfern, A., Bauwens, A., Craft, P., Webb, S., Townsend, A., & Kotasek, D. (2014). Phase II, open-label trial of lapatinib and vinorelbine in women with previously treated HER2-positive metastatic breast cancer.

Chicago

Chan, Arlene, C. Shannon, R. De Boer, S. Baron-Hay, A. Redfern, A. Bauwens, P. Craft, S. Webb, A. Townsend, and D. Kotasek. 2014. “Phase II, Open-Label Trial of Lapatinib and Vinorelbine in Women with Previously Treated HER2-Positive Metastatic Breast Cancer.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1033960980&authtype=sso&custid=ns315887.